Skip to content

Drug interactions

Mercaptopurine + Ocrelizumab

Severity: Moderate

Mercaptopurine and Ocrelizumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ocrelizumab depletes B cells and mercaptopurine suppresses lymphocytes generally, so combined use is expected to increase the risk of infection. The effect may persist after either drug is stopped.

What this interaction means in plain words

Mercaptopurine and Ocrelizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mercaptopurine belongs to Oncology; Ocrelizumab belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive immunosuppression through CD20-mediated B-cell depletion and thiopurine-mediated lymphocyte suppression.

What to do

Monitor for infection and check blood counts. Reassess the need for concomitant immunosuppressants and treat infections promptly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mercaptopurine and Ocrelizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mercaptopurine with Ocrelizumab?

MediHelp rates the interaction as moderate. Mercaptopurine and Ocrelizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ocrelizumab depletes B cells and mercaptopurine suppresses lymphocytes generally, so combined use is expected to increase the risk of infection. The effect may persist after either drug is stopped.

How serious is the interaction between Mercaptopurine and Ocrelizumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and check blood counts. Reassess the need for concomitant immunosuppressants and treat infections promptly.

What other medicines interact with Mercaptopurine?

MediHelp also lists interactions of Mercaptopurine with, for example, Adenovirus types 4 and 7 live, Azathioprine, Bcg vaccine live. The full list is on the Mercaptopurine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in